Hylan G-F 20 induces delayed foreign body inflammation in guinea pigs and rabbits

Toxicologic Pathology

Volumn 31, Issue 3, 2003, Pages 321-325

  Sasaki, Masanori ^a   Miyazaki, Yuka ^a   Takahashi, Toyomi ^a  

^a SEIKAGAKU CORPORATION   (Japan)

Author keywords

Biocompatibility; Foreign body inflammation; Hyaluronan; Hylan

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; HYLAN G F 20; IMMUNOGLOBULIN G; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; FOREIGN BODY; GIANT CELL; GRANULOMATOUS INFLAMMATION; GUINEA PIG; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKIN ANAPHYLAXIS;

ANIMALS; DISEASE MODELS, ANIMAL; FOREIGN-BODY REACTION; GUINEA PIGS; HYALURONIC ACID; IMMUNE SERA; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MALE; MUSCLE, SKELETAL; PASSIVE CUTANEOUS ANAPHYLAXIS; RABBITS; SKIN;

ANIMALIA; CAVIA; CAVIA PORCELLUS; ORYCTOLAGUS CUNICULUS; SUS SCROFA;

EID: 0037910344     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230309758     Document Type: Article

References (22)

1. Adams ME, Lussier AJ, Peyron JG (2000). A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Saf 23: 115-130.
2. Adams ME, O'Hanlon D, Puttick MP, Chalmers A, Wade JP (1996). Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 23: 944-945.
3. Allen E, Krohn K (2000). Adverse reaction to Hylan GF-20 (letter). J Rheumatol 27: 1572.
4. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (2000). Recommendation for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 43: 1905-1915.
5. Balazs EA, Bland PA, Denlinger JL, Goldman AI, Larsen NE, Leshchiner EA, Leshchiner A, Morales B (1991). Matrix engineering. Blood Coagul Fibrinolysis 2: 173-178.
6. Bucher W, Otto T (2001). Differentiation of hyaluronate products by qualitative differences of immunogenicity in rabbits - Relationship to clinical flares? [abstract] J Rheumatol 28(Suppl 63): 9.
7. Chen AL, Desai P, Adler EM, Di Cesare PE (2002). Granulomatous inflammation after hylan G-F 20 viscosupplementation of the knee. J Bone Joint Surg Am 84: 1142-1147.
8. D'Hermies F, Korobelnik JF, Caputo G, Mashhour B, Chauvaud D, Pouliquen Y, Renard G (1998). Encapsulation of scleral buckling materials: A study of sixty specimens. Ophthalmology 105: 1079-1086.
9. Goomer RS, Leslie K, Maris T, Amiel D (2002). Immunogenicity of hyaluronic acid products: Comparison of Synvisc and Artz in guinea pigs. [abstract] 4th International Cartilage Repair Society Symposium. Toronto, Canada, June 2002.
10. Griffiths MM, Langone JJ, Lightfoote MM (1996). Biomaterials and granulomas. Methods (San Diego, CA) 9: 295-304.
11. Larsen NE, Pollak CT, Reiner K, Leishchiner E, Balazs EA (1993). Hylan gel biomaterial: Dermal and immunologic compatibility. J Biomed Mater Res 27: 1129-1134.
12. Lowe NJ, Maxwell CA, Lowe P, Duick MG, Shah K (2001). Hyaluronic acid skin fillers: Adverse reactions and skin testing. J Am Acad Dermatol 45: 930-933.
13. Martens PB (2001). Bilateral symmetric inflammatory reaction to hylan G-F 20 injection. Arthritis Rheum 44: 978-979.
14. Micheels P (2001). Human anti-hyaluronic acid antibodies: Is it possible? Dermatol Surg 27: 185-191.
15. Piacquadio D, Jarcho M, Goltz R (1997). Evaluation of hylan b gel as a soft-tissue augmentation implant material. J Am Acad Dermatol 36: 544-549.
16. Puttick MP, Wade JP, Chalmers A, Connell DG, Rango KK (1995). Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 22: 1311-1314.
17. Raurin C, Greve B, Hartschuh W, Soegding K (2000). Exudative granulomatous reaction to hyaluronic acid (Hylaform). Contact Dermatitis 43: 178-179.
18. Rees JD, Wojtulewski JA (2001). Systemic reaction to viscosupplementation for knee osteoarthritis. Rheumatology 40: 1425-1426.
19. Richter W (1974). Non-immunogenicity of purified hyaluronic acid preparations tested by passive cutaneous anaphylaxis. Int Arch Allergy Appl Immunol 47: 211-217.
20. Richter AW, Ryde EM, Zetterstrom EO (1979). Non-immunogenicity of a purified sodium hyaluronate preparations in man. Int Arch Allergy Appl Immunol 59: 45-48.
21. Verdier F, Chazal I, Descotes J (1994). Anaphylaxis models in guinea-pig. Toxicology 93: 55-61.
22. Zardawi IM, Chan I (2001). Synvisc perisynovitis. Pathology 33: 519-520.